Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-44-2-coppola Categories: Psychopharmacology Bulletin, VOL 44 No. 2 Articles Tags: antipsychotic, caroline-lannie, danielle-coppola, david-hough, extended-release, isaac-nuamah, jaskaran-singh, joseph-palumbo, lowest-effective-dose, medworks-media, paliperidone, psychopharmacology-bulletin, rama-melkote, schizophrenia, srihari-gopal

Description

Description

ORIGINAL RESEARCH

Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day—A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia

Danielle Coppola, Rama Melkote, Caroline Lannie, Jaskaran Singh, Isaac Nuamah, Srihari Gopal, David Hough, Joseph Palumbo

PB-44-2-2011-Coppola